DE SARRO, GIOVAMBATTISTA
 Distribuzione geografica
Continente #
NA - Nord America 15.458
AS - Asia 9.675
EU - Europa 4.544
SA - Sud America 2.083
AF - Africa 273
OC - Oceania 100
Continente sconosciuto - Info sul continente non disponibili 26
AN - Antartide 2
Totale 32.161
Nazione #
US - Stati Uniti d'America 14.757
SG - Singapore 4.269
CN - Cina 2.202
IT - Italia 1.740
BR - Brasile 1.607
IN - India 986
VN - Vietnam 954
GB - Regno Unito 651
DE - Germania 615
CA - Canada 524
SE - Svezia 441
HK - Hong Kong 348
FI - Finlandia 286
AR - Argentina 163
FR - Francia 135
NL - Olanda 125
ID - Indonesia 118
MX - Messico 118
BD - Bangladesh 96
AU - Australia 90
JP - Giappone 90
RU - Federazione Russa 84
ZA - Sudafrica 83
EC - Ecuador 82
CO - Colombia 72
PK - Pakistan 72
IQ - Iraq 70
AE - Emirati Arabi Uniti 64
ES - Italia 64
TR - Turchia 62
CL - Cile 61
UA - Ucraina 57
RO - Romania 54
EG - Egitto 49
PL - Polonia 46
UZ - Uzbekistan 44
KR - Corea 36
SA - Arabia Saudita 36
IR - Iran 33
VE - Venezuela 30
MA - Marocco 28
PY - Paraguay 28
CZ - Repubblica Ceca 26
PH - Filippine 26
IL - Israele 24
MY - Malesia 24
AT - Austria 23
CH - Svizzera 23
IE - Irlanda 23
PE - Perù 22
TN - Tunisia 19
GR - Grecia 18
EU - Europa 17
PT - Portogallo 17
KE - Kenya 16
TW - Taiwan 16
DO - Repubblica Dominicana 15
EE - Estonia 14
NP - Nepal 14
UY - Uruguay 14
JO - Giordania 13
NO - Norvegia 12
RS - Serbia 11
LT - Lituania 10
AZ - Azerbaigian 9
HN - Honduras 9
KZ - Kazakistan 9
NZ - Nuova Zelanda 9
SK - Slovacchia (Repubblica Slovacca) 9
TH - Thailandia 9
A2 - ???statistics.table.value.countryCode.A2??? 8
AL - Albania 8
DZ - Algeria 8
JM - Giamaica 8
KW - Kuwait 8
MD - Moldavia 8
NG - Nigeria 8
SC - Seychelles 8
HR - Croazia 7
MT - Malta 7
AO - Angola 6
BE - Belgio 6
SN - Senegal 6
BG - Bulgaria 5
CI - Costa d'Avorio 5
CR - Costa Rica 5
ET - Etiopia 5
LB - Libano 5
LK - Sri Lanka 5
SY - Repubblica araba siriana 5
UG - Uganda 5
BH - Bahrain 4
BO - Bolivia 4
CY - Cipro 4
GH - Ghana 4
GT - Guatemala 4
SI - Slovenia 4
TT - Trinidad e Tobago 4
AF - Afghanistan, Repubblica islamica di 3
BA - Bosnia-Erzegovina 3
Totale 32.091
Città #
San Jose 2.252
Dallas 2.016
Singapore 1.711
Chandler 1.671
Ashburn 1.120
Santa Clara 697
Bengaluru 616
Milan 605
Hefei 596
Princeton 531
Lawrence 519
Munich 475
Chicago 397
Shenzhen 397
London 395
Ho Chi Minh City 353
Ottawa 337
Hong Kong 318
Wilmington 317
Beijing 311
Des Moines 185
Hanoi 185
Catanzaro 180
São Paulo 166
New York 144
Helsinki 138
Boardman 126
Turku 126
Los Angeles 122
Brooklyn 82
Redwood City 82
The Dalles 75
Tokyo 71
Council Bluffs 61
Columbus 59
Rio de Janeiro 55
Norwalk 52
Haiphong 51
Pune 49
Amsterdam 47
Rome 47
Shanghai 47
Johannesburg 45
Montreal 45
Boston 44
Da Nang 44
Chennai 43
Orem 43
Tashkent 40
Guangzhou 39
Curitiba 38
Mexico City 37
Palermo 37
San Francisco 37
Jakarta 35
Guayaquil 34
Redmond 34
Toronto 34
Atlanta 32
Melbourne 30
Porto Alegre 30
Hải Dương 29
Warsaw 29
Santiago 28
Seattle 28
West Jordan 28
Brasília 27
Naples 27
Stockholm 27
Belo Horizonte 26
Campinas 26
Falls Church 26
Phoenix 26
Biên Hòa 25
Buenos Aires 25
Bogotá 24
Florence 23
Istanbul 23
Mumbai 23
Buffalo 22
Hyderabad 22
San Nicola Manfredi 22
Augusta 21
Catania 21
Charlotte 21
Manchester 21
Padova 21
Thái Bình 21
Messina 20
Dhaka 19
Olomouc 19
Quito 19
Baghdad 18
Bologna 17
Delhi 17
Bari 16
Houston 16
New Delhi 16
Ninh Bình 16
Santa Maria 16
Totale 19.376
Nome #
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 621
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 516
1-Aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents 486
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study 431
Adherence to therapy and adverse drug reactions: is there a link? 287
Adverse effects of atypical antipsychotics in the elderly: a review 284
Adverse drug reactions during biologic therapy in inflammatory disease: real life data from the pharmacovigilance project in the Calabria region 247
Palmitoylethanolamide modulates pentobarbital-evoked hypnotic effect in mice Involvement of allopregnanolone biosynthesis 230
Management of psychogenic non-epileptic seizures: a multidisciplinary approach 181
Neuropharmacology of depression in aging and age-related diseases 171
A Comprehensive Safety Evaluation of Trabectedin and Drug-Drug Interactions of Trabectedin-Based Combinations 165
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities 163
Genetics of reflex seizures and epilepsies in humans and animals 157
Conventional and new antidepressant drugs in the elderly 151
A POSSIBLE DRUG-FOOD INTERACTION INDUCED GENERALISED URTICARIA IN A YOUNG WOMAN 146
First evidence of an altered microbiota and intestinal damage and its link to absence epilepsy in a genetic animal model, the WAG/Rij rat 132
25-Hydroxy Vitamin D Detection Using Different Analytic Methods in Patients with Migraine 124
Venlafaxine-Propafenone interaction resulting in hallucinations and psychomotor agitation 123
Conventional and atypical antipsychotics in the elderly - A review 118
Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release 118
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 116
Transient Receptor Potential Ankyrin 1 (TRPA1) mediates hydrogen sulfide-induced Ca2+ entry and nitric oxide production in human cerebrovascular endothelium. 115
High Prevalence of Achilles Tendon Enthesopathic Changes in Patients with Type 2 Diabetes Without Peripheral Neuropathy 112
Efficacy and safety of bevacizumab in glioblastomas 110
Tolerance to anticonvulsant effects of some benzodiazepines in genetically epilepsy prone rats 109
Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy 109
Uno strano caso di deterioramento cognitivo: quando le interazioni farmaco-alimenti diventano fondamentali. 107
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 105
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 103
Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 101
Effects of early long-term treatment with antiepileptic drugs on development of seizures and depressive-like behavior in a rat genetic absence epilepsy model 101
Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model 101
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 97
A Brain-To-SONAR Electronic Interface to Bypass Peripheral Auditory System in RATS 97
Targeting alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy 97
A review on antiepileptic drugs-dependent fatigue: Pathophysiological mechanisms and incidence 92
Antiabsence effects of carbenoxolone in two genetic animal models of absence epilepsy (WAG/Rij rats and lh/lh mice) 91
Cerebral small vessel disease predisposes to temporal lobe epilepsy in spontaneously hypertensive rats 90
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 88
Lamotrigine potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 88
Audiogenic epileptic DBA/2 mice strain as a model of genetic reflex seizures and SUDEP 85
A Case of Interstitial Lung Disease Probably Related to Rituximab Treatment 85
Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy 85
Safety profile of biologic drugs for psoriasis in clinical practice: An Italian prospective pharmacovigilance study 85
9-cis Retinoic acid modulates myotrophin expression and its miR in physiological and pathophysiological cell models 84
Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice 84
Tryptase-positive mast cells and angiogenesis in keloids: a new possible post-surgical target for prevention 83
Increased efficacy of combining prebiotic and postbiotic in mouse models relevant to autism and depression 83
N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy 83
Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease 82
Melaena following use of the cholinesterase inhibitor rivastigmine 82
Chlorpromazine versus sleep deprivation in activation of EEG in adult-onset partial epilepsy. 81
T-type channel blocking properties and antiabsence activity of two imidazo [1,2-b]pyridazine derivatives structurally related to indomethacin 80
Amino acid levels in some brain areas of inducible nitric oxide synthase knock out mouse (iNOS(-/-)) before and after pentylenetetrazole kindling 80
3D pharmacophore models for 1,2,3,4-tetrahydroisoquinoline derivatives acting as anticonvulsant agents 80
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 80
QUINOLONES POTENTIATE CEFAZOLIN-INDUCED SEIZURES IN DBA/2 MICE 79
Amino acid levels in some lethargic mouse brain areas before and after pentylenetetrazole kindling 79
The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model 79
Neuroactive steroids and GABA(A) receptor plasticity in the brain of the WAG/Rij rat, a model of absence epilepsy 79
A Rare Case of Drug-Induced Erectile Dysfunction with Secukinumab Solved After Switch to Ixekizumab in A Psoriatic Patient: A Case Report 78
Determination of a potent non-competitive AMPA receptor antagonist in rat brain 78
InVivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 78
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus: Data from an in vivo model 78
Effects of some neurosteroids injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy 77
Apomorphine-induced neurodegeneration in Mongolian gerbil hippocampus 77
IL-6 Receptor Blockade by Tocilizumab Has Anti-absence and Anti-epileptogenic Effects in the WAG/Rij Rat Model of Absence Epilepsy 77
Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity 77
A case of neuroleptic malignant syndrome induced by risperidone in a schizophrenic woman 76
Cathepsin-K is a potential cardiovascular risk biomarker in prevalent hemodialysis patients 76
Evaluation of the effects of liraglutide on the development of epilepsy and behavioural alterations in two animal models of epileptogenesis 76
Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy 76
Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice 74
Lithium in late-life mania: a systematic review 74
Vitamin D Serum Levels in Subjects Tested for SARS-CoV-2: What Are the Differences among Acute, Healed, and Negative COVID-19 Patients? A Multicenter Real-Practice Study 74
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy 73
Potential effects of current drug therapies on cognitive impairment in patients with type 2 diabetes 73
Data recorded in real life support the safety of nattokinase in patients with vascular diseases 73
Biologics for Inflammatory Bowel Disease in Clinical Practice: A Calabria (Southern Italy) Prospective Pharmacovigilance Study 72
Antiepileptogenic effects of Ethosuximide and Levetiracetam in WAG/Rij rats are only temporary 72
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 72
Adverse drug reactions related to drug administration in hospitalized patients. 72
Seizure susceptibility to various convulsant stimuli in dystrophin-deficient mdx mice 71
A fatal case of triple whammy in an elderly patient 71
Anticholinergic drug-induced delirium in an elderly Alzheimer's dementia patient 70
Implementing a simple pharmacovigilance program to improve reporting of adverse events associated with biologic therapy in rheumatology: Preliminary results from the Calabria Biologics Pharmacovigilance Program (CBPP) 70
Asterixis as initial manifestation of cerebellar ischemic stroke 70
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 69
Protective activity of α-lactoalbumin (ALAC), a whey protein rich in tryptophan, in rodent models of epileptogenesis. 69
Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy 69
Liraglutide prevents cognitive decline in a rat model of streptozotocin-induced diabetes independently from its peripheral metabolic effects 69
A case of adverse drug reaction induced by dispensing error 69
Anti TNF.alpha biologic agents and insulin resistence in rheumatoid arthritis: A systematic review and Meta-analysis. Journal of Biological Regulators & Homeostatic Agents 69
Safety profiles of biologic agents for inflammatory bowel diseases: a prospective pharmacovigilance study in Southern Italy 69
Metabolic Alterations Predispose to Seizure Development in High-Fat Diet-Treated Mice: the Role of Metformin 69
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 68
Non-competitive AMPA glutamate receptors antagonism by perampanel as a strategy to counteract hippocampal hyper-excitability and cognitive deficits in cerebral amyloidosis 68
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 68
The cAMP-HMGA1-RBP4 system: a novel biochemical pathway for modulating glucose homeostasis 68
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations 68
Totale 11.415
Categoria #
all - tutte 277.903
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 277.903


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021109 0 0 0 0 0 0 0 0 0 76 23 10
2021/20221.556 5 15 23 420 52 40 24 338 197 187 234 21
2022/20234.748 1.094 216 92 447 480 427 35 371 779 331 365 111
2023/20242.877 475 292 588 157 136 543 116 119 44 122 106 179
2024/20257.094 962 344 370 306 477 907 450 294 848 360 669 1.107
2025/202615.076 698 1.700 2.667 2.490 1.579 566 2.027 856 1.684 809 0 0
Totale 32.685